Lorfast 10 mg Tablet
PDF Leaflet Revision Date: 09 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with seasonal allergic rhinitis and chronic urticaria.
Dosage (summary)
Adults: one tablet daily, limited to 14 days.
Special Populations
- Elderly
- Children under 2
- Severe liver impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; avoid use during pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP2D6 inhibitors
- Cimetidine
- Ketoconazole
- Clarithromycin
- Erythromycin
Contraindications
- Hypersensitivity to loratadine
- Cross sensitivity to antihistamines
- Porphyria
Common side effects
- Headache
- Somnolence
- Dry mouth
- Nausea
- Rash
Counselling Points
- Limit use to 14 days
- Avoid alcohol and CNS depressants
- Determine individual response before driving
Serious warnings
- Use with caution in severe liver impairment
- May cause sedation in some individuals
Important Disclaimer
The Lorfast 10 mg Tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
